ECHOSTAR CORP-A (SATS) Fundamental Analysis & Valuation

NASDAQ:SATS • US2787681061

110.72 USD
+2.22 (+2.05%)
Last: Mar 11, 2026, 12:59 PM

This SATS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Overall SATS gets a fundamental rating of 1 out of 10. We evaluated SATS against 91 industry peers in the Media industry. SATS has a bad profitability rating. Also its financial health evaluation is rather negative. SATS is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. SATS Profitability Analysis

1.1 Basic Checks

  • SATS had positive earnings in the past year.
  • In the past year SATS has reported a negative cash flow from operations.
  • In multiple years SATS reported negative net income over the last 5 years.
  • Of the past 5 years SATS 4 years had a positive operating cash flow.
SATS Yearly Net Income VS EBIT VS OCF VS FCFSATS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5B -10B

1.2 Ratios

  • With a Return On Assets value of -33.70%, SATS is not doing good in the industry: 74.73% of the companies in the same industry are doing better.
  • SATS has a Return On Equity of -251.43%. This is in the lower half of the industry: SATS underperforms 79.12% of its industry peers.
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROIC N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
SATS Yearly ROA, ROE, ROICSATS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • SATS has a worse Gross Margin (25.82%) than 68.13% of its industry peers.
  • SATS's Gross Margin has declined in the last couple of years.
  • SATS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.82%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
SATS Yearly Profit, Operating, Gross MarginsSATS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50

0

2. SATS Health Analysis

2.1 Basic Checks

  • SATS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, SATS has more shares outstanding
  • Compared to 5 years ago, SATS has more shares outstanding
  • SATS has a worse debt/assets ratio than last year.
SATS Yearly Shares OutstandingSATS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SATS Yearly Total Debt VS Total AssetsSATS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • SATS has an Altman-Z score of 0.55. This is a bad value and indicates that SATS is not financially healthy and even has some risk of bankruptcy.
  • SATS has a Altman-Z score (0.55) which is in line with its industry peers.
  • A Debt/Equity ratio of 3.24 is on the high side and indicates that SATS has dependencies on debt financing.
  • SATS's Debt to Equity ratio of 3.24 is on the low side compared to the rest of the industry. SATS is outperformed by 74.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Altman-Z 0.55
ROIC/WACCN/A
WACC7.62%
SATS Yearly LT Debt VS Equity VS FCFSATS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • SATS has a Current Ratio of 0.42. This is a bad value and indicates that SATS is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.42, SATS is doing worse than 80.22% of the companies in the same industry.
  • A Quick Ratio of 0.38 indicates that SATS may have some problems paying its short term obligations.
  • SATS has a Quick ratio of 0.38. This is amonst the worse of the industry: SATS underperforms 82.42% of its industry peers.
Industry RankSector Rank
Current Ratio 0.42
Quick Ratio 0.38
SATS Yearly Current Assets VS Current LiabilitesSATS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

4

3. SATS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 1628.89% over the past year.
  • SATS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.00% yearly.
  • SATS shows a decrease in Revenue. In the last year, the revenue decreased by -5.18%.
  • Measured over the past years, SATS shows a very strong growth in Revenue. The Revenue has been growing by 51.37% on average per year.
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%

3.2 Future

  • The Earnings Per Share is expected to decrease by -15.91% on average over the next years. This is quite bad
  • SATS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.25% yearly.
EPS Next Y-153.58%
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%
EPS Next 5Y-15.91%
Revenue Next Year-2.6%
Revenue Next 2Y-2.01%
Revenue Next 3Y-1.09%
Revenue Next 5Y-0.25%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SATS Yearly Revenue VS EstimatesSATS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B
SATS Yearly EPS VS EstimatesSATS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -10 -20 -30 -40

1

4. SATS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.09, which indicates a correct valuation of SATS.
  • Compared to the rest of the industry, the Price/Earnings ratio of SATS indicates a somewhat cheap valuation: SATS is cheaper than 73.63% of the companies listed in the same industry.
  • SATS's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.25.
  • SATS is expected to report negative earnings next year, which makes the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE 16.09
Fwd PE N/A
SATS Price Earnings VS Forward Price EarningsSATS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SATS is valued a bit more expensive than the industry average as 61.54% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 35.55
SATS Per share dataSATS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40 50

4.3 Compensation for Growth

  • A cheap valuation may be justified as SATS's earnings are expected to decrease with -48.43% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%

0

5. SATS Dividend Analysis

5.1 Amount

  • SATS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

SATS Fundamentals: All Metrics, Ratios and Statistics

ECHOSTAR CORP-A

NASDAQ:SATS (3/11/2026, 12:59:57 PM)

110.72

+2.22 (+2.05%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)03-02
Earnings (Next)05-07
Inst Owners96.74%
Inst Owner Change-8.99%
Ins Owners12.11%
Ins Owner Change1.03%
Market Cap31.87B
Revenue(TTM)15.00B
Net Income(TTM)-14.50B
Analysts74.29
Price Target118.22 (6.77%)
Short Float %22.56%
Short Ratio5.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)339.66%
Min EPS beat(2)-463.29%
Max EPS beat(2)1142.6%
EPS beat(4)2
Avg EPS beat(4)174.08%
Min EPS beat(4)-463.29%
Max EPS beat(4)1142.6%
EPS beat(8)3
Avg EPS beat(8)88.21%
EPS beat(12)6
Avg EPS beat(12)20.43%
EPS beat(16)8
Avg EPS beat(16)28.88%
Revenue beat(2)0
Avg Revenue beat(2)-3.28%
Min Revenue beat(2)-5.46%
Max Revenue beat(2)-1.09%
Revenue beat(4)0
Avg Revenue beat(4)-3.22%
Min Revenue beat(4)-5.46%
Max Revenue beat(4)-1.09%
Revenue beat(8)0
Avg Revenue beat(8)-2.77%
Revenue beat(12)1
Avg Revenue beat(12)-3.2%
Revenue beat(16)4
Avg Revenue beat(16)-2.11%
PT rev (1m)1.25%
PT rev (3m)51.84%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-12.82%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.24%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.4%
Valuation
Industry RankSector Rank
PE 16.09
Fwd PE N/A
P/S 2.12
P/FCF N/A
P/OCF N/A
P/B 5.53
P/tB 5.58
EV/EBITDA 35.55
EPS(TTM)6.88
EY6.21%
EPS(NY)-3.69
Fwd EYN/A
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS52.12
BVpS20.03
TBVpS19.84
PEG (NY)N/A
PEG (5Y)N/A
Graham Number55.68
Profitability
Industry RankSector Rank
ROA -33.7%
ROE -251.43%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.82%
FCFM N/A
ROA(3y)-12.29%
ROA(5y)-6.56%
ROE(3y)-86.86%
ROE(5y)-50.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.13%
GM growth 5Y-15.68%
F-Score3
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF N/A
Debt/EBITDA 12.49
Cap/Depr 60.91%
Cap/Sales 6.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.42
Quick Ratio 0.38
Altman-Z 0.55
F-Score3
WACC7.62%
ROIC/WACCN/A
Cap/Depr(3y)111.73%
Cap/Depr(5y)101.51%
Cap/Sales(3y)11.48%
Cap/Sales(5y)15.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1628.89%
EPS 3Y49%
EPS 5YN/A
EPS Q2Q%-441.46%
EPS Next Y-153.58%
EPS Next 2Y-55.78%
EPS Next 3Y-48.43%
EPS Next 5Y-15.91%
Revenue 1Y (TTM)-5.18%
Revenue growth 3Y95.83%
Revenue growth 5Y51.37%
Sales Q2Q%-4.31%
Revenue Next Year-2.6%
Revenue Next 2Y-2.01%
Revenue Next 3Y-1.09%
Revenue Next 5Y-0.25%
EBIT growth 1Y70.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.85%
EBIT Next 3Y32%
EBIT Next 5Y18.28%
FCF growth 1Y-263.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-107.93%
OCF growth 3YN/A
OCF growth 5YN/A

ECHOSTAR CORP-A / SATS FAQ

Can you provide the ChartMill fundamental rating for ECHOSTAR CORP-A?

ChartMill assigns a fundamental rating of 1 / 10 to SATS.


What is the valuation status of ECHOSTAR CORP-A (SATS) stock?

ChartMill assigns a valuation rating of 2 / 10 to ECHOSTAR CORP-A (SATS). This can be considered as Overvalued.


How profitable is ECHOSTAR CORP-A (SATS) stock?

ECHOSTAR CORP-A (SATS) has a profitability rating of 1 / 10.


Can you provide the financial health for SATS stock?

The financial health rating of ECHOSTAR CORP-A (SATS) is 0 / 10.